Certified-PEP Launches Two New Research Peptide Sites as Black Friday Peptide Deal Interest Builds

Nov 7, 2026

Black Friday Peptide Deals and Peptides For Sale put twelve lab-tested research compounds in one place as buyers get ready for the holiday sale season.

San Diego, United States, November 7, 2026 -- San Diego, CA – Certified-PEP is a research peptide company that supplies U.S.-made, research-use-only (RUO) peptides, and today it announced the launch of two new microsites: Black Friday Peptide Deals at https://blackfridaypeptidedeals.us.com/ and Peptides For Sale at https://peptidesforsale.us.com/. Each site gives researchers one organized page to browse twelve compounds from the Certified-PEP catalog, including BPC-157, TB-500, GLOW and KLOW, with a direct link to every product page.

The launch comes as excitement builds across the peptide market. With Black Friday arriving on November 27, researchers and lab buyers are looking for the best deals on peptides, and many want to compare options, volume savings and testing documentation before they order. The two new sites were built to make that comparison faster and clearer, with every product page lightning fast with a clean UX.

“Every year around Black Friday, researchers start hunting for the best deals on peptides, and this year the excitement in the market is hard to miss,” said Benson Jamison of Certified Peptides. “We wanted to give people a clear, easy place to see the full lineup, the volume savings and the lab testing behind every batch before they place an order.”

What Each Site Offers

  • Black Friday Peptide Deals collects twelve research peptides on a single deals page. Certified-PEP applies volume savings automatically at checkout: 5% off three to five vials of the same product and 10% off six or more.
  • Peptides For Sale is a collection page for the same twelve compounds, organized by category (repair, blends, growth and metabolic) alongside the lyophilized vials, capsules, lipotropics and bundles in the wider Certified-PEP catalog.
  • Both sites include a research library and a certificate of analysis (COA) guide that explains how to read a lab report.

Researchers should watch for price adjustments of 30-40% with the upcoming holiday. Prices, promotions and availability are set by Certified-PEP and may change without notice.

Testing and Transparency

Certified-PEP emphasizes U.S. manufacturing in a cGMP-compliant facility and independent, batch-specific testing, most often through Vanguard Laboratory, an ISO/IEC 17025:2017 accredited lab. Every vial carries a QR code that opens that lot’s report on the testing lab’s own website. The company reports more than 200,000 orders filled and more than 7,000 verified customer reviews.

A Fast-Growing Category

Public interest in peptides is growing quickly:

  • A November 2025 KFF poll found about 1 in 8 U.S. adults (12%) said they were taking a peptide.
  • A May 2026 Hone Health survey of 2,491 peptide-aware U.S. adults found 83% support letting licensed compounding pharmacies make popular peptides with a prescription. 39% said FDA reclassification would be the biggest reason they would try peptides or use them more.
  • New Beauty’s 2026 State of Aesthetics research found only 12.3% of beauty consumers recognize BPC-157, even as 47.9% of peptide users spend $1,000 or more a year on peptide therapies or weight-loss drugs.
  • Grand View Research valued the global peptide therapeutics market at $140.9 billion in 2025 and projects it will reach $294.6 billion by 2033. That figure is driven largely by approved drugs such as GLP-1s, not research peptides.

The Regulatory Picture

The regulatory landscape is also changing. In April 2026, the FDA removed 12 peptides from its Category 2 “significant safety risk” list, including BPC-157, TB-500, KPV, and injectable GHK-Cu. On July 23, 2026, the FDA’s Pharmacy Compounding Advisory Committee voted 8 to 6, with one abstention, to recommend BPC-157, TB-500, and KPV for the 503A bulk drugs list. Injectable GHK-Cu is due for review before the end of February 2027.

Removal from Category 2 does not make a peptide approved or eligible for compounding. All Certified-PEP products are sold strictly for laboratory research use and are not for human consumption.

New Research Content

Both sites are publishing educational material for researchers, including guides to reading a peptide COA and choosing a peptide supplier.

Learn More

To browse the Black Friday lineup or explore the full collection, visit the two sites listed above.

Certified-PEP is a U.S.-based supplier of peptides and compounds for qualified laboratory research. The company emphasizes U.S. manufacturing, batch-specific analytical testing through Vanguard Laboratory, product labeling with COA information, transparent research documentation and top-tier customer service. Certified-PEP products are intended solely for in-vitro laboratory research and are not intended for human or veterinary use or clinical applications.

Research Use Only: Certified-PEP products are intended solely for in-vitro laboratory research and are not intended for human or veterinary use, consumption, clinical use, diagnosis, treatment or prevention of disease. Statements in this release have not been evaluated by the U.S. Food and Drug Administration.

About Certified PEP

Black Friday Peptide Deals and Peptides For Sale are resource sites that list twelve research compounds from the Certified-PEP catalog, with organized educational content, COA guidance and links to each product page. All products referenced are intended solely for in-vitro laboratory research and are not intended for human or veterinary use or clinical applications. No dosing or administration guidance is provided.

Contact Info:
Name: Benson Jamison
Email: Send Email
Organization: Certified PEP
Phone: 8058893321
Website: https://certified-pep.com/

Release ID: 89208818

Should you detect any errors, issues, or discrepancies with the content contained within this press release, or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond and take necessary steps within the next 8 hours to resolve any identified issues or guide you through the removal process. We value the trust placed in us by our readers and remain dedicated to providing accurate and reliable information.

MORE NEWS
DOST to showcase new agri-aqua technologies at 2026 NSTW
Nov 6, 2026
DOST to showcase new agri-aqua technologies at 2026 NSTW

MANILA, Philippines — The Department of Science and Technology (DOST) will showcase three agricultural and aquaculture innovations at the 2026 National Science, Technology, and Innovation Week (NSTW) in General Santos City, on November 25–29.  The annual NSTW serves as a platform for presenting locally developed technologies and research initiatives that highlight the country’s scientific and

Tesla winding down Cybertruck production
Nov 6, 2026
Tesla winding down Cybertruck production

Elon Musk announced Friday that Tesla will wind down production of its Cybertruck next year after years of poor sales for the electric truck. In a post on the social platform X, the Tesla CEO said Cybertruck production will wind down at Gigafactory Texas in mid-2027 "to make room for increased Cybercab production." The Texas...

Fed's Williams says inflation too high, targets 2 percent
Nov 6, 2026
Fed's Williams says inflation too high, targets 2 percent

John Williams, the president of the Federal Reserve Bank of New York, said Friday inflation remains too high amid multiple price shocks. "Inflation is absolutely too ​high. It's been too high for too long," Williams said at a ​European Central Bank conference in Germany. He later added, "It's absolutely essential that we bring inflation back...

Automatic noise-cancellation in calls debuts in the Philippines
Nov 6, 2026
Automatic noise-cancellation in calls debuts in the Philippines

In the past, having noise-cancellation features in your calls or while listening to music was always on the hardware side. Devices such as the Samsung Buds 4 Pro or Apple’s own AirPods would have hardware-powered noise cancellation features that would drive up the price of devices. You can tell from the pricing – where regular

eGovPH superapp to include SSS services, digital ID
Nov 6, 2026
eGovPH superapp to include SSS services, digital ID

MANILA, Philippines – The Social Security System (SSS) and the Department of Information and Communications Technology (DICT) signed a data-sharing agreement to bring the MySSS card and select member services to the eGovPH superapp. Members will also be able to view their contribution history, their total number of contributions, and employer information on integration. “Our

China’s AI chipmakers report first profits, but will the trend continue?
Nov 6, 2026
China’s AI chipmakers report first profits, but will the trend continue?

China’s pure-play artificial intelligence chipmakers crossed an important milestone in the third quarter as several firms swung into profit, but severe supply chain hurdles and soaring memory costs cloud their long-term growth prospects. Domestic graphics processing unit (GPU) developers including Moore Threads, MetaX and Iluvatar CoreX are racing to fill the market void left by Nvidia, whose high-end processors face strict US export controls. These home-grown firms are competing fiercely to win...

Nvidia finalizes payment of $1 bil., acquires over 4% stake in Naver
Nov 6, 2026
Nvidia finalizes payment of $1 bil., acquires over 4% stake in Naver

Nvidia Corp. has finalized its payment of $1 billion of investments to Naver Corp. on Friday and acquired 4.13 percent of the portal operator's shares through a third-party rights offering. The South Korean company said it has issued over 6.5 million shares through a private placement involving the U.S. chipmaker, after receiving 1.3 trillion won ($1 billion) in proceeds, according to its regulatory filing. Nvidia's stake acquisition of Naver is set to speed up their joint artificial intelligence (AI) factory venture announced in June. Naver plans to construct graphics processing unit (GPU)-based infrastructure, starting with its Gak Sejong data center in the central city, to expand its GPU-as-a-service businesses.

Temu says 91% of surveyed Korean sellers report business gains
Nov 6, 2026
Temu says 91% of surveyed Korean sellers report business gains

Chinese e-commerce platform Temu said Friday that a survey it conducted found that 91 percent of Korean sellers reported improvements in their businesses after joining the online marketplace, including increased sales and access to new customers. The company-run survey of more than 100 sellers, conducted in August, found that 58 percent reported higher sales volumes, while 47 percent said they had reached new customer groups. Temu entered Korea in July 2023 and fully introduced its Local Seller Program in May last year, allowing domestic merchants to sell to consumers nationwide. About 66 percent of the survey respondents had been selling on the platform for six months or less. Businesses with fewer than 50 employees accounted for 85 percent of the respondents, while 94 percent had already sold through other online channels before joining Temu. Meanwhile, 82 percent viewed Temu as a sales channel that complements their existing sales routes or as a major driver of sales growth. Another 39 percent said they had expanded their operations after joining Temu or planned to do so within 12 mon

Samsung Biologics labor dispute drags on as union stages another strike
Nov 6, 2026
Samsung Biologics labor dispute drags on as union stages another strike

Samsung Biologics' unionized workers staged another strike Friday, as wage and collective bargaining negotiations between labor and management have dragged on for more than six months. With global rivals moving quickly to expand their contract drug manufacturing capability, concerns are growing that the prolonged labor dispute could undermine Samsung Biologics' reputation as a reliable supplier capable of delivering the promised volumes of drugs on time. The Samsung Biologics labor union said it began its partial strike on Friday, without holding a separate rally. The strike is scheduled to continue for about three weeks, through Nov. 27. About 400 workers, or 10 percent of the union's roughly 4,000 members, are participating in the strike. They work in departments including quality control testing, quality assurance, logistics and production. Samsung Biologics’ labor and management declared a breakdown in their 2026 wage and collective bargaining negotiations in March, prompting the union to stage a partial strike in April, the first since the company was established in 2011. The union

Lotte Chemical remains in red in Q3
Nov 6, 2026
Lotte Chemical remains in red in Q3

Lotte Chemical Corp. on Friday reported its third-quarter net loss of 289.8 billion won ($213.6 million), remaining in the red compared with a year ago. The company, which makes advanced chemical products and battery materials, said in a regulatory filing that it continued to post an operating loss of 281.4 billion won for the July-September period, compared with a loss of 132.6 billion won a year earlier. Sales rose 12.7 percent to 5.39 trillion won.

Hanwha Engine Q3 net profit down 61.7% to $8.6 mil.
Nov 6, 2026
Hanwha Engine Q3 net profit down 61.7% to $8.6 mil.

Hanwha Engine on Friday reported its third-quarter net income of 11.6 billion won ($8.6 million), down 61.7 percent from a year earlier. The company, which is part of Korea's largest weapons producer Hanwha Group, said in a regulatory filing that its operating profit for the July-September period stood at 40.9 billion won, up 53.7 percent from a year ago. Sales also rose 39.1 percent to 413.6 billion won. The earnings failed to meet market expectations. The average estimate of net profit by analysts stood at 41.6 billion won, according to a survey by Yonhap Infomax, the financial data firm of Yonhap News Agency.

4 decades on, Maestro charts new course in Italian elegance
Nov 6, 2026
4 decades on, Maestro charts new course in Italian elegance

Introduced in 1986, LF's premium menswear brand Maestro is one of Korea's longest-running menswear labels, having spent four decades adapting its styles and sizing to better suit Korean men's physiques. Marking its 40th anniversary this year, LF said the brand will be more faithful to “Italian elegance” and seek broader global markets beyond Vietnam. LF announced last month that it will further strengthen Albero, Maestro's high-end line featuring Italian-made products, by expanding partnerships with leading Italian textile manufacturers, including Zegna, Loro Piana, Colombo and Piacenza. The company will also expand its made-to-measure (MTM) tailoring services, which account for 30 percent of the brand's sales, by dividing them into three categories: Su Misura, Alta Sartoria and Sartoria Italia. To cater to growing demand from couples preparing for their weddings and consumers in their 20s and 30s who increasingly reserve suits for special occasions, the brand will also expand its formalwear lineup. The Rome Suit, launched in September to celebrate the brand's 40th anniversary, is de

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

About Us

Always dynamic, always updated, The Witness Daily ensures minute-by-minute update to the most pressing issues, curated specifically to cater to critical newsreaders of our time.

Copyright © 2015 - 2026 Redshift Daily. All Rights Reserved.